We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
California’s HeartVista has teamed with Germany-based Siemens Healthineers to co-market an automated cardiac magnetic resonance (CMR) imaging exam platform that takes up less scanner time and requires no additional training for technicians. Read More
Lantheus, which specializes in radiopharmaceutical diagnostic and therapeutic products, will pay $260 million in upfront license fees — with potential for another $1.8 billion — for worldwide rights to two of POINT Biopharma’s late-stage cancer therapeutic candidates. Read More
The potential for cleanroom contamination and other deficiencies led to a Form 483 for UFP Technologies, following an FDA inspection of the company’s Chicopee, Mass. facility. Read More
WCG Imaging has been named one of this year’s top 10 medical device testing and certification companies by MedTech Outlook, a medical technology publication. Read More
Sweden’s SciBase has teamed up with Johnson & Johnson (J&J) to develop an augmented intelligence (AI)-based screening tool to predict a common type of eczema, atopic dermatitis, in infants. Read More
Thermo Fisher Scientific announced it will purchase The Binding Site Group, a UK-based developer of specialty assays and instruments for diagnosis and management of blood cancers and immune system disorders, for $2.6 billion. Read More
Johnson & Johnson (J&J) announced Tuesday that it would acquire Massachusetts-based Abiomed, gaining access to the medical device company’s Impella heart pump, which treats conditions such as heart attack, heart failure and clogged arteries. J&J will pay $380 per share upfront in cash, which equates to a value of approximately $16.6 billion. Read More
Indianapolis, Ind.-based medical device cybersecurity company TRIMEDX has partnered with Indiana University (IU) Health to create a cybersecurity lab that will test the security of medical devices as part of the development process. Read More
Medtronic is spinning off its patient monitoring and respiratory interventions businesses into a new, independent entity that has yet to be named. Read More
Baxter said users and facilities should “stop use of all WatchCare system accessories where possible until this functionality is temporarily disabled and while Baxter continues to work to determine the cause of this problem.” Read More
Cordis has acquired Switzerland-based MedAlliance and its Selution SLR (sustained limus release) drug-eluting balloon — an alternative to the paclitaxel-coated balloons that have raised concerns among regulators because of the risk to patients with peripheral arterial disease (PAD). Read More